TENORMIN Solution for injection

Active ingredients: Atenolol

Product name and form

Tenormin Injection 0.5 mg/ml.

Pharmaceutical Form

Solution for injection or infusion.

Type I clear glass ampoules containing a clear, colourless, sterile solution.

Qualitative and quantitative composition

Atenolol 0.5 mg/ml (5 mg in 10 ml).

For the full list of excipients, see section 6.1.

Active Ingredient

Atenolol is a beta-blocker which is beta1-selective, (i.e. acts preferentially on beta1-adrenergic receptors in the heart). Atenolol is without intrinsic sympathomimetic and membrane-stabilising activities and as with other beta-blockers, has negative inotropic effects.

List of Excipients

Citric acid
Sodium chloride
Sodium hydroxide
Water for Injection

Pack sizes and marketing

Glass ampoules.

10 ml ampoules are packed in boxes of 10.

Marketing authorization holder

AstraZeneca UK Limited, 600 Capability Green, Luton, LU1 3LU, UK

Marketing authorization dates and numbers


Date of first authorisation: 1st June 2000

Date of latest renewal: 18th February 2004


Austria, Australia, Canada, Cyprus, Germany, Ecuador, Spain, Hong Kong, Italy, Japan, Malta, Mexico, Nigeria, Singapore, United Kingdom, United States, South Africa